We supply a large range of compliant plastic containers for solid and liquid dose use.
Closures & Dispensers
See our child resistant and tamper evident closures and our range of innovative dispensers.
We make speciality pharmaceutical coil which is 100% cotton for moisture control.
Origin Pharma Packaging are leaders in innovation and design, global manufacturing, and consolidation of your packaging supply chain. We work with international pharmaceutical companies and healthcare agencies to create new solutions, reduce costs, and increase speed to market.
Product Design and Development
From concept development to completed commercial-ready product, our customer-led packaging & device product programme allows you to develop unique packaging and devices. Everything we design is compliant, high quality, and bespoke.
Our unique manufacturing model allows us to place tooling in strategic geographic locations; utilising a range of production techniques, reducing our carbon footprint, and increasing speed to market.
We drive innovation and excellence in child resistant design. We have a market-leading passion for protecting children in the domestic environment.
We have a dedicated NPD department who are continually researching and developing new pharmaceutical packaging designs and healthcare devices.
Find out more in our intelligent packaging in our innovation zone. If you need support with a project, talk to the NPD team today.
The Impacts of Brexit on the UK Pharma Industry
Origin Pharma Contributed an article to EPM Magazine – full story below Like every industry, the pharma sector is poised on the edge of its seat in anticipation of a final agreement on Brexit. The UK will officially leave the European Union on March 29th (if all goes to plan) and the terms of the...
Pharmaceutical Packaging – What to Expect in 2019
By Rich Quelch, Global Head of Marketing, Origin Pharmaceutical packaging is an industry going from strength to strength and its shows no signs of slowing down. In fact, by 2025 the market is expected to be worth $128 billion. The main drivers of this growth are: increased global demand for medication from emerging economies; an ageing...
The role of pharma packaging innovation in tackling antibiotic resistance
By Rich Quelch, Global Head of Marketing, Origin Antimicrobial resistance (AMR) is a complex and global issue, affecting all regions of the world. If current trends continue, it’s believed by 2050 antibiotic resistance will cause more deaths per year than cancer, becoming the world’s biggest killer. As such, AMR is currently high on the political...
Blue Ocean Strategy:
It’s very easy to go about your day to day life without thinking about the impact the products you buy and use have on the environment. Although there has been a surge in interest in single-use plastics, the reality is that many of us aren’t aware of the damage we’re doing to the planet. Every...
Keeping up with biologics:
GSK, Bristol-Myers Squibb, Novartis and AstraZeneca to name but a few are investing billions of dollars in biologics to have prime mover advantage in a market forecast to be worth nearly $480 billion by 2024. It’s clear biologics are the future of medicine based on their proven ability to treat major chronic diseases better than...